Rights and permissions
About this article
Cite this article
Imperfect HIV vaccines could still be cost effective. Pharmacoecon. Outcomes News 168, 6 (1998). https://doi.org/10.1007/BF03284910
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03284910